Published in Peptides on September 15, 2010
Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells. J Mol Med (Berl) (2004) 1.46
Mechanisms of genetically-based resistance to malaria. Gene (2010) 1.37
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. Vaccine (2002) 1.16
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol (2003) 1.14
Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem Rev (2008) 1.06
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J Hepatol (2002) 0.95
Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem Biophys Res Commun (2004) 0.94
Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. Vaccine (2002) 0.94
Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res (2008) 0.93
Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: possible misannotation of this tubercle bacilli-hemolysin. BMC Struct Biol (2011) 0.92
Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules. J Biol Chem (2010) 0.92
Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci (2005) 0.92
Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine (2009) 0.91
Computational prediction and experimental assessment of secreted/surface proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol (2010) 0.91
Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol (2011) 0.90
Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration. Pharm Res (2004) 0.89
Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis. Exp Parasitol (2009) 0.89
Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1)-derived peptides. Protein Sci (2005) 0.88
Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. J Biol Chem (2006) 0.88
Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun (2005) 0.87
PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar J (2011) 0.87
Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells. J Biol Chem (2005) 0.87
Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Infect Genet Evol (2010) 0.87
Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue. Biochem Biophys Res Commun (2007) 0.86
Reference strand conformational analysis (RSCA) is a valuable tool in identifying MHC-DRB sequences in three species of Aotus monkeys. Immunogenetics (2006) 0.86
Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2. Biochem Biophys Res Commun (2005) 0.86
Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein. Biochem Biophys Res Commun (2006) 0.85
Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine (2004) 0.85
Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions. Biochimie (2005) 0.85
High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Infect Genet Evol (2005) 0.85
The Plasmodium vivax rhoptry-associated protein 1. Biochem Biophys Res Commun (2006) 0.85
Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants. Clin Diagn Lab Immunol (2002) 0.85
Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics (2009) 0.84
Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages. Immunogenetics (2006) 0.84
Plasmodium vivax Duffy binding protein peptides specifically bind to reticulocytes. Peptides (2002) 0.84
Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34). Vaccine (2009) 0.84
The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods (2012) 0.84
MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochem Biophys Res Commun (2004) 0.84
Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women. J Clin Microbiol (2013) 0.84
Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes. Biochem Biophys Res Commun (2004) 0.84
Antigenic properties of the Leishmania infantum GRP94 and mapping of linear B-cell epitopes. Immunol Lett (2002) 0.84
Conserved high activity binding peptides are involved in adhesion of two detergent-resistant membrane-associated merozoite proteins to red blood cells during invasion. J Med Chem (2010) 0.84
Identification of the Plasmodium falciparum rhoptry neck protein 5 (PfRON5). Gene (2010) 0.83
Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. Biochem Biophys Res Commun (2005) 0.83
Characterisation of the Plasmodium vivax Pv38 antigen. Biochem Biophys Res Commun (2008) 0.83
Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes. Peptides (2002) 0.83
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides (2005) 0.83
The Plasmodium vivax Pv41 surface protein: identification and characterization. Biochem Biophys Res Commun (2008) 0.83
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC Microbiol (2010) 0.83
Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Sci (2005) 0.83
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC. Vaccine (2007) 0.83
Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Malar J (2011) 0.83
Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection. Vaccine (2009) 0.82
Cutaneous tuberculosis diagnosis in an inhospitable Amazonian region by means of telemedicine and molecular biology. J Am Acad Dermatol (2005) 0.82
The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys. Vaccine (2007) 0.82
Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci (2011) 0.82
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP). Vaccine (2003) 0.81
Allele effects in MHC-peptide interactions: a theoretical analysis of HLA-DRbeta1*0101-HA and HLA-DRbeta1*0401-HA complexes. Biochem Biophys Res Commun (2005) 0.81
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev (2006) 0.81
Limited genetic polymorphism of the Plasmodium vivax low molecular weight rhoptry protein complex in the Colombian population. Infect Genet Evol (2009) 0.81
Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. PLoS One (2013) 0.81
Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Vaccine (2003) 0.81
Differential expansion of the merozoite surface protein (msp)-7 gene family in Plasmodium species under a birth-and-death model of evolution. Mol Phylogenet Evol (2010) 0.81
Protection against experimental malaria associated with AMA-1 peptide analogue structures. FEBS Lett (2002) 0.81